Massachusetts Sues J&J Over Risperdal Marketing Practices
This article is for subscribers only.
Massachusetts’s attorney general sued Johnson & Johnson’s Ortho-McNeil-Janssen unit for improper marketing of the anti-psychotic drug Risperdal.
The company marketed the drug as a treatment for dementia in the elderly and a way to ease various ailments of younger people when those uses hadn’t been approved by the U.S. Food and Drug Administration, Attorney General Martha Coakley said today in a statement.